1,849
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Long noncoding RNA PP7080 promotes hepatocellular carcinoma development by sponging mir-601 and targeting SIRT1

ORCID Icon, , , , , & show all
Pages 1599-1610 | Received 30 Nov 2020, Accepted 17 Apr 2021, Published online: 06 May 2021

References

  • Saran U, Humar B, Kolly P, et al. Hepatocellular carcinoma and lifestyles. J Hepatol. 2016;64(1):203–214.
  • Wallace MC, Preen D, Jeffrey GP, et al. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol. 2015;9(6):765–779.
  • Klingenberg M, Matsuda A, Diederichs S, et al. Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets. J Hepatol. 2017;67(3):603–618.
  • Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155–159.
  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
  • Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.
  • Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–866.
  • Kong YW, Ferland-mccollough D, Jackson TJ, et al. microRNAs in cancer management. Lancet Oncol. 2012;13(6):e249–e258.
  • Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015;5(10):1122–1143.
  • Wang Q, Huang Z, Ni S, et al. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. Plos One. 2012;7(9):e44398.
  • Ohdaira H, Nakagawa H, Yoshida K. Profiling of molecular pathways regulated by microRNA 601. Comput Biol Chem. 2009;33(6):429–433.
  • He Y, Meng X-M, Huang C, et al. Long noncoding RNAs: novel insights into hepatocelluar carcinoma. Cancer Lett. 2014;344(1):20–27.
  • Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX Loci by noncoding RNAs. Cell. 2007;129:1311–1323.
  • Huang W, Liu Z, Li Y, et al. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma. J Cell Biochem. 2019;120(3):4121–4131.
  • Wu X, Cao N, Fenech M, et al. Role of Sirtuins in Maintenance of Genomic Stability: relevance to cancer and healthy aging. DNA Cell Biol. 2016;35(10):542–575.
  • Min L, Ji Y, Bakiri L, et al. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat Cell Biol. 2012;14(11):1203–1211.
  • Rüster B, Grace B, Seitz O, et al. Induction and detection of human mesenchymal stem cell migration in the 48-well reusable transwell assay. Stem Cells & Development. 2005;14(2):231–235.
  • Kim J, Aydemir TB, Jimenez-Rondan FR, et al. Deletion of metal transporter Zip14 (Slc39a14) produces skeletal muscle wasting, endotoxemia, Mef2c activation and induction of miR-675 and Hspb7. Sci Rep. 2020;10(1):4050.
  • Min C, Zhang A, Qin J. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer. Diagn Pathol. 2019;14(1):107.
  • Onishi M, Ochiya T, Tanaka Y. MicroRNA and liver cancer. Cancer Drug Resistance. 2020;3:385–400.
  • Song Y, He S, Zhuang J, et al. MicroRNA‑601 serves as a potential tumor suppressor in hepatocellular carcinoma by directly targeting PIK3R3. Mol Med Rep. 2019;19(3):2431–2439.
  • Du H, Wang X, Dong R, et al. miR-601 inhibits proliferation, migration and invasion of prostate cancer stem cells by targeting KRT5 to inactivate the Wnt signaling pathway. Int J Clin Exp Pathol. 2019;12(12):4361–4379.
  • Chen J, Zhang B, Wong N, et al. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. Cancer Res. 2011;71(12):4138–4149.
  • Portmann S, Fahrner R, Lechleiter A, et al. Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo. Mol Cancer Ther. 2013;12(4):499–508.
  • Cao W, Jin H, Zhang L, et al. Identification of miR-601 as a novel regulator in the development of pancreatic cancer. Biochem Biophys Res Commun. 2017;483(1):638–644.
  • Lu F, Zhou Q, Liu L, et al. A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients. Theranostics. 2020;10(2):484–497.